ConductScience.org, home

Gene · 55215

FANCI: FA complementation group I

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. FANCI: FA complementation group I. Genes, record 55215. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55215

On this page

Gene

Symbol
FANCI
HGNC
Name
FA complementation group I
HGNC
NCBI Gene ID
55215
NCBI Gene
HGNC ID
HGNC:25568
HGNC
Ensembl
ENSG00000140525
NCBI Gene
Aliases
FLJ10719, KIAA1794
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9NVI1Fanconi anemia group I protein1,3288Ensembl, GeneID, HGNC

Source UniProt

Patents22

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026501822 A2026-01-167Q9NVI1Espacenet
JP 2026004568 A2026-01-1445848Q9NVI1Espacenet
EP 4650780 A22025-11-194717Q9NVI1Espacenet
EP 4641201 A22025-10-294288Q9NVI1Espacenet
EP 4641202 A22025-10-294858Q9NVI1Espacenet
JP 2025517969 A2025-06-124288Q9NVI1Espacenet
JP 2025517970 A2025-06-124717Q9NVI1Espacenet
KR 1020250017231 A2025-02-044858Q9NVI1Espacenet
US 11976334 B22024-05-07152Q9NVI1Espacenet
US 11446398 B22022-09-2030673Q9NVI1Espacenet

1 to 10 of 22

See all 22 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,231

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleFANCI papersNewest fiscal year
R01HL052725Molecular Pathogenesis of Fanconi Anemia212025
P01CA092584Structural Cell Biology of DNA Repair Machines202025
P30CA008748Cancer Center Support Grant162025
P30CA016672Cancer Center Support Grant162025
ZIAHG000029Fanconi Anemia: Genotype-Phenotype Correlations112025
R01CA168635Mechanistic Dissection of the BRCA1-SETX-dependent Pathway of R-loop Avoidance and Genome Maintenance102025
ZIAAG000688Investigate the DNA damage response pathway of Fanconi anemia and BRCA proteins102025
ZIAAG000746Repair of localized DNA damage102025
ZIACP010144Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes102025
R01AG011085Ubiquitin‐mediated proteolysis and cell cycle control82025

1 to 10 of 1,231Source NIH's project files

See all 1,231 nih grants

Papers1,818

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Perioperative and Clinicopathologic Outcomes of Patients with Young-Onset Renal Cell Carcinoma.Clin Genitourin Cancer202642805854PubTator, text miningPubMed
Severe Macrocytic Anemia Associated With a Novel ALAS2 Mutation: A Case Report and Literature Review.Clin Case Rep202642757146PubTator, text miningPubMed
FANCI: from genome guardian to translational therapeutic target.Front Oncol202642444811PubTator, text miningPubMed
Germline Predisposition in Pediatric Central Nervous System Tumors: Insights from a Multigene Panel Study.Oncol Res202642232602PubTator, text miningPubMed
Functional analysis of a splicing variant of the DOCK8 gene in a patient with breast cancer (Buryat ethnicity).Asian Pac J Cancer Prev202642169560PubTator, text miningPubMed
Integrative Bioinformatic Analysis Identifies Key Genes Driving Breast Cancer Brain Metastasis.Diagnostics (Basel)202642072775PubTator, text miningPubMed
Functional significance of miR-218 in lung cancer.J Cancer Metastasis Treat202641924446PubTator, text miningPubMed
Micronuclei: origins, assays, mechanisms, diseases and treatments.Signal Transduct Target Ther202641888103PubTator, text miningPubMed
An updated view on lagging strand DNA replication: implications for the replication stress response.Cell Cycle202641865289PubTator, text miningPubMed
EEPD1 evolved a unique DNA clamping dimer protecting reversed replication forks.Nucleic Acids Res202641830330PubTator, text miningPubMed

1 to 10 of 1,818

See all 1,818 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/55215

GET https://conductscience.org/api/genes/v1/55215/patents?page=2